Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     

  • OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD

    2,349.60
    +7.10 (+0.30%)
     

  • Bitcoin AUD

    95,917.02
    -2,143.81 (-2.19%)
     

  • CMC Crypto 200

    1,316.60
    -79.93 (-5.72%)
     

  • AUD/EUR

    0.6108
    +0.0035 (+0.57%)
     

  • AUD/NZD

    1.0994
    +0.0037 (+0.33%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Company News for Nov 30, 2021

Zacks Equity Research
·1-min read

  • Krystal Biotech, Inc.’s KRYS shares jumped more than 100% after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational beremagene geperpavec for dystrophic Epidermolysis Bullosa.

  • Shares of Adagio Therapeutics, Inc. ADGI surged 86.4% after the company reported that its COVID-19 monoclonal antibody, ADG20, is likely to retain activity against Omicron, as observed in in vitro models with all other variants of concern identified previously.

  • NRx Pharmaceuticals, Inc.’s NRXP shares jumped 20% after the company announced positive data from its ZYESAMI study.

  • Shares of Hertz Global Holdings, Inc. HTZ rose nearly 6% after the car rental company announced a new stock repurchase program of up to $2 billion.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Hertz Global Holdings, Inc. (HTZ) : Free Stock Analysis Report
 
Krystal Biotech, Inc. (KRYS) : Free Stock Analysis Report
 
NRx Pharmaceuticals, Inc. (NRXP): Free Stock Analysis Report
 
Adagio Therapeutics, Inc. (ADGI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research